Ovoca Bio | OVG - Current Liabilities


Ovoca Bio reported EUR1.3M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.35M 1.48M Sep/2026
Alaunos Therapeutics USD 864K 269K Jun/2026
ALKERMES USD 651.93M 10.16M Sep/2026
Avita Medical AUD 68.71M 6.04M Jun/2026
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Great Western Mining Corporation EUR 770.4K 18.57K Dec/2025
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 2.03B 506M Sep/2026
Organon & Co USD 2.65B 36M Sep/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Revvity USD 701.48M 574.88M Sep/2026
Tectonic Therapeutic USD 10.37M 2.59M Jun/2026
Viatris USD 6.64B 290.7M Sep/2026
Xeris Pharmaceuticals USD 134.48M 55.09M Sep/2026